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Glomerular filtration during furosemide diuresis in the dog. Si-
multaneous clearance and micropuncture experiments were per-
formed in pentobarbital-anesthetized dogs to determine the ef-
fect of furosemide (F; 5 mg/kg) on some of the determinants of
GFR during replacement of urine losses. Glomerular capillary
pressure (PG) was estimated from stop flow pressure (SFP) plus
systemic colloid osmotic pressure (7r). Because renal vasodila-
tion during F administration occurs more often when blood pres-
sure is elevated, two groups of dogs were studied. At endoge-
nous renal perfusion pressure (RPP) of 130 mm Hg, one group
responded to F with a 28% increase in renal blood flow (RBF). PG
rose (a rise of 18 mm Hg) in proportion to the rise in proximal
tubule pressure (PT) (a rise of 20 mm Hg). Thus, the difference in
pressures (PG — PT) was unchanged, as was GFR. The second
group had RPP lowered by renal artery constriction to a point
near the lower limit of autoregulation (104 mm Hg). These dogs
responded to F with no increase in RBF; PG was lower and
remained constant during F. PT, however, increased (a rise of 10
mm Hg). The difference in pressures (P) decreased by 30%, and
GFR decreased by 40%. Single nephron glomerular filtration rate
(SNGFR) also decreased, and estimated Kf, the ultrafiltration co-
efficient, actually rose slightly. The major reason for the fall in
GFR and SNGFR was due to a decrease in P rather than a
decrease in K1. The decrease in P can be attributed to failure of
the renal vasculature to dilate because PG and RBF remained
constant. It is likely that these events will be observed less often
at hypertensive BP than at normal BP where renal vascular re-
sistence is already close to a minimum value.
Filtration glomérulaire au cours de Ia diurèse par le furosémide
chez le chien. Des clearances et des microponctions ont été rëa-
lisées simultanément sous anesthésie générale par le pentobarbi-
tal chez des chiens afin d'étudier l'effet du furosémide (F; 5 mg/
kg) sur les determinants du GFR au cours du remplacement des
pertes urinaires. La pression capillaire glomérulaire (PG) a été
évaluée a partir de Ia pression de stop-flow (SFP) et de Ia pres-
sion colloido-osmotique systémique (ira). Du fait que Ia vasodi-
latation rénale au cours de l'administration de F survient le plus
souvent quand la pression sanguine est élevée, deux groupes de
chiens ont été étudiés. A Ia pression de perfusion basale (RPP)
de 130 mm Hg un groupe répond a F par une augmentation de
28% du debit sanguin renal (RBF). PG augmente (l'augmentation
de 18 mm Hg) en proportion de l'augmentation de la pression
tubulaire proximale (P1) (l'augmentation de 20 mm Hg). Ainsi,
P (PG — PT) n'est pas modifié, il en est de méme pour GFR.
Dans le deuxième groupe RPP a été diminué par une constriction
de l'artère rénale jusqu'à une valeur proche de Ia limite in-
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féneure de l'autoregulation (104 mm Hg). Ces chiens repondent
a F sans augmentation de RBF, PG est plus bas et n'est pas modi-
flC par F, cependant PT augmente (l'augmentation de 10 mm Hg).
P diminue de 30% et GFR de 40%. Le debit de filtration des
néphrons individuels (SNGFR) diminue aussi et le coefficient
d'ultrafiltration calcule Kf augmente un peu. La cause Ia plus im-
portante de la diminution de GFR et de SNGFR est une diminu-
tion de zP, plus qu'une diminution de Kf. La diminution de P
peut être attribuée a l'impossibilitC, pour les vaisseaux rCnaux,
de se dilater puisque PG et RBF restent constants. Ii est probable
que ces évènements seraient observes moms souvent a des
pressions artérielles élevées qu'à une pression normale oü Ia ré-
sistance vasculaire est déjà proche de sa valeur minimale.
Following the administration of the loop-acting
diuretic furosemide, whole-kidney GFR has been
reported to decrease [1, 2] or remain unchanged [3,
4] despite replacement of urinary losses. This diu-
retic inhibits tubular reabsorption of salt and water,
which can lead to an elevation of hydrostatic pres-
sure within the nephron. Thus, it is possible that the
rise in intratubular pressure, specifically in the prox-
imal tubule (PT), might lead to a decrease in effective
filtration pressure (EFP) and thus may result in a
reduced GFR. Furosemide, however, can also in-
crease renal blood flow (RB F) and decrease renal
vascular resistance (RVR) [5—7]. It is conceivable
that this decrease in vascular resistance across the
kidney would allow an increased fraction of system-
ic arterial pressure to be transmitted into the gb-
merular capillaries, which would tend to offset in-
creases in PT. Therefore, the balance between in-
creased glomerular capillary pressure (PG) and
increased PT may determine the response of GFR
during furosemide diuresis.
The purpose of the present study was to evaluate
some of the parameters which determine GFR in
the dog during furosemide diuresis. Because
changes in RBF and RVR can alter PG, we studied
the effect of furosemide on GFR under two experi-
mental conditions, that is, in the presence and the
absence of an increase in RBF induced by furose-
mide. We recently have demonstrated in the dog
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that the increase in RBF following furosemide is
proportional to and dependent upon the level of re-
nal perfusion pressure (RPP) such that renal vasodi-
lation and hyperemia are evident at RPP's greater
than 120 mm Hg, but are not apparent at RPP's of
100 mm Hg or lower [7]. Therefore, one series of
experiments was performed at the dog's endoge-
nous or normal blood pressure, where hyperemia in
response to furosemide is clearly evident, and a sec-
ond series of animals was studied at a reduced RPP,
where RBF does not increase after furosemide.
Methods
Twenty-two mongrel dogs of either sex (each
weighing 15 to 20 kg) were anesthetized with so-
dium pentobarbital (30 mg/kg, i.v.) and intubated
with a cuffed endotracheal tube. Polyethylene cath-
eters were inserted in peripheral veins for infusion
of solutions and drugs. During surgery and until
completion of the control period, saline was infused
at 4 mi/mm. This modest volume load was used to
insure acceptable urine flow rates for clearance de-
terminations. Inulin (8%) in 0.9% saline was infused
at 1.0 mI/mm via a femoral vein to maintain plasma
levels at approximately 100 mgldl. The left femoral
artery was catheterized to collect arterial blood
samples and to monitor systemic arterial blood
pressure with a Harvard pressure transducer (Har-
vard Apparatus Co., Inc., model 377). Both ureters
were cannulated with polyethylene tubing via su-
prapubic incision for urine collections.
The left kidney was approached through a sub-
costal, retroperitoneal incision, and the renal ar-
tery, vein, and ureter were carefully separated. An
electromagnetic flow probe was placed around the
base of the renal artery for continuous measure-
ment of RBF (Carolina Medical Electronics, Inc.,
King, North Carolina). A 23-gauge needle con-
nected to a second Harvard transducer was inserted
against the direction of flow into the renal artery
near the renal hilus to monitor RPP. This line was
kept patent by a constant infusion of heparinized
saline at 0.2 ml/min. A plastic adjustable clamp was
placed between the needle and the probe to alter
unilateral RPP. The kidney was placed in a plastic
holder (Lucite), and approximately 2 cm2 of renal
capsule was removed. The kidney surface was
bathed with a warmed (370 C) solution of isotonic
saline, and then the kidney was insulated with warm
saline-soaked gauze and covered with a plastic wrap.
Proximal tubular pressure (PT) was determined
directly using a micropressure servo-null device
(W-P Instruments, model 911, New Haven, Con-
necticut) and recorded on a Biograph® recorder.
Micropipettes having a tip diameter of 3 .t were
used for all micropressure determinations. The pro-
cedure for measuring stop-flow pressure (SFP) was
as follows. An early proximal nephron was identi-
fied with the micropressure pipette by an intra-
luminal injection of 1 M sodium chloride tinted with
0.05% Fast green. When a stable pressure was re-
corded, a second pipette was placed distal to the
micropressure pipette, and Sudan-black-stained
castor oil was injected into the lumen until pressure
reached a maximum stable value (Fig. 1). Three
measurements were made for each PTP and SFP
and were averaged for each time interval studied.
Peritubular capillary pressure (Pa) was also mea-
sured.
In the first series of experiments, which consisted
of eight dogs, standard clearance and micropressure
measurements were made before and 10 to 20 mm
after furosemide (5 mg/kg plus 5 mg/kg/hr. i.v.) at
endogenous blood pressure. New nephrons were
punctured for all measurements during furosemide.
To study the effect of furosemide on the determi-
nants of GFR when RBF does not increase after fu-
rosemide, we studied renal function in a second se-
ries of eight dogs at a RPP which had been reduced
to a level near the lower limit of RBF autoregula-
tion. For these studies, a RBF autoregulatory curve
for each dog was determined as described in an ear-
lier publication [7]. To remain within the autoregu-
lation range for whole-kidney and superficial single
nephron function [8], RPP was reduced to about 10
to 15 mm Hg above the lower limit of RBF autoreg-
ulation. The lower limit of RBF autoregulation is
the lowest RPP at which whole kidney RBF does
not vary by more than 10% of control RBF at con-
trol RPP. At this reduced pressure level, micro-
pressure and whole-kidney clearance measure-
ments were made before and again between 10 and
20 mm after furosemide (5 mg/kg plus 5 mg/kg/hr,
i.v.); RPP was maintained constant by adjustment
of the plastic clamp.
In six dogs (group II) and five dogs (group I),
complete, timed collections of proximal tubule fluid
were obtained for determination of single nephron
glomerular filtration rate (SNGFR). Re-collections
from these same nephrons were obtained between
15 and 20 mm after furosemide administration. The
volume (in nanoliters) of each sample was measured
in a constant-bore capillary tube, and duplicate de-
terminations of tubular fluid (TF) inulin concentra-
tion were made with our modification [9] of the ul-
tramicrofluorometric technique of Vurek and Pe-
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Fig. 1. Mean arterial blood pressure (MABP), mean renal per-
fusion pressure (RPP.I, and mean renal blood flow (RBF during
the time when proximal tubule pressure (PTP) and stop flow
pressure were being measured. Injection of Sudan black castor
oil is indicated by the arrow. A plateau, stable pressure was
achieved in about 20 sec. At 1 and at2, intratubular pressure was
purposely lowered by applying suction to the oil injection sy-
ringe. MABP averaged 136 mm Hg, RPP averaged 124 mm Hg,
and RBF averaged 215 mI/mm.
gram [10]. SNGFR was calculated from the product
of tubular flow rate and the tubular fluid to plasma
inulin concentration ratio.
Because it is well known that furosemide increas-
es the release of renin, which elevates angiotensin
II (All), the determinants of GFR were also mea-
sured in the presence of an angiotensin II antagonist
(SartGly8) during furosemide diuresis in a third
group of dogs. Following a control period, Sar1Gly8
(1 sg/kg/min) dissolved in 0.9% sodium chloride
was infused i.v. for at least 15 mm. This dose
blocked the vasoconstrictive response (BP and
RBF) to 500 ng All, i.v. Micropressure measure-
ments were initiated during the infusion of the an-
tagonist alone and then repeated during combined
antagonist and furosemide infusion (5 mg/kg plus 5
mg/kg/hr, i.v.).
In all studies during furosemide, urine output was
carefully and continuously replaced with isotonic
saline. Urine was collected in a graduated cylinder
while replacement saline was infused from another
graduated cylinder. The rate of replacement was
controlled with a Holter pump. Inulin concentration
in the plasma and urine was determined using the
Technicon autoanalyzer. Urine sodium concentra-
tion was measured by the flame photometer (Instru-
mentation Labs.). Microhematocrit measurements
were performed on all arterial blood samples. Pro-
tein concentration in each plasma sample was mea-
sured with a protein refractometer (American Opti-
cal Corp.). All values represent the means SEM.
Student's t test was used for paired analysis, and
significance was accepted at P < 0.05.
Calculations. GFR was estimated by the clear-
ance of inulin. Systemic colloid osmotic pressure
(ir), which was presumed to be equal to afferent arte-
riolar colloid osmotic pressure (ira), was calculated
using the Landis-Pappenheimer equation [11]. The
modification derived by Navar and Navar [12] was
not used because albumin : globulin ratios exceed
1.0 in our dogs (Table 1). No correction for the
slight overestimation (0.34 g/dl) of the protein con-
centration, reportedly inherent in refractometer-
based measurements, was used [13]. Glomerular
capillary pressure (PG) was calculated by the sum of
SFP and lTa. Effective hydrostatic filtration pressure
(P) was taken to be P0 — PT. Efferent arteriolar
oncotic pressure (iTe) was determined indirectly
from the iTa and whole kidney filtration fraction, ac-
cording to the formula ire = ira (1 / 1 — FF). Other
laboratories have reported that the indirect method
for determining ire closely agrees with the direct
method for determination of efferent arteriolar pro-
tein concentration [14, 15] or with another indirect
method based upon efferent arteriolar hematocrit
[13]. We measured efferent arteriolar hematocrit in
seven dogs and calculated superfical FF from the
relationship:
Ha
FF =
—
where Ha and He represent systemic and efferent
hematocrit, respectively. The average superficial
FF agreed closely with whole kidney FF based up-
on RBF, systemic hematocrit, and GFR (Fig. 2).
Mean glomerular oncotic pressure (irG) was esti-
mated by (ira + ire)!2 because both Deen et al [16]
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Dog no.
Total
proteina
gidI
Albumin
to globulin
ratio
Albumin
gidi
1 4.4 1.56 2.7
2 4.4 1.48 2.6
3 4.6 1.16 2.5
4 3.8 1.62 2.4
5 4.4 1.32 2.5
Mean SEM 4.32 0.14 1.43 0.08 2.54 0.05
a Serum analysis was by spectrophotometric method and elee-
trophoresis.
and Knox et al [17] have demonstrated this approxi-
mation to be valid when ire is less than 80% of P.
Effective filtration pressure (EFP) was calculated as
PG — PT — Tg
K, the ultraffitration coefficient, in nanoliters per
minute per millimeter of mercury, was estimated at
both the reduced and endogenous RPP before and
again during furosemide from the following relation-
ship:
-
SNGFRKf EFP
Results
0.2 0.3
Filtration fraction )whole kidney)
Fig. 2. A comparison between filtration fra ction based on whole
kidney clearance measurements and that based on superficial
nephron efferent arteriolar hemotocrits. Mean value is denoted
by closed triangle. Average whole kidney filtration fraction was
0.22 0.02and superficial nephron filtration fraction was 0.26
0.04.
As explained in the introduction, the present
study sought to determine whether decreases in
GFR, often reported following F administration,
could be attributed to a decrease in EFP, in K, or in
both. Particular attention was directed at the pre-
existing RBF and RPP, because the state of renal
vascular resistence prior to F administration may
determine whether or not renal vasodilation occurs
with the drug. Table 2 summarizes the whole kidney
and micropressure responses to F. When RPP was
131 mm Hg, F administration resulted in no change
in GFR, yet RBF increased by 28% from 195 28
mi/mm to 250 37 mllmin (P < 0.01). Whole kidney
filtration fraction (FF) decreased from 0.27 0.02
to 0.19 0.02 (P < 0.01). Sodium excretion in-
creased from 46 15 to 872 159 Eq!min (P <
0.0 1).
Free-flow PT, which was already elevated (31 2
mm Hg) by the volume of fluid administered, in-
creased significantly (P < 0.01) to 51 5 mm Hg.
Stop-flow pressure increased from 53 2 to 71 2
mm Hg (P < 0.01). Estimated PG (ira + SFP) in-
creased from 66 1 mm Hg before F to 84 1 mm
Hg during F; however, neither P, which averaged
35 1 mm Hg before F and 33 1 mm Hg after F,
nor ITG changed appreciably. EFP averaged 18 2
mm Hg prior to F and was unchanged during the
Table 2. Effect of furosemide on whole-kidney and
micropressure hemodynamic parameters at endogenous renal
perfusion pressurea
Control Furosemide
Whole kidney
RPP,mmHg 131 5 134 4
GFR, mi/mm 24 3 23 3
RBF,ml/min 195 28 250 37C
FF 0.27 0.02 0.19 0.02c
UNaV,p.Eq/min 46 15 872 159e
Micropressure
PT, mm Hg 31 2 51 5
ra,mmHg 13 1 13 1
ITG,mmHg 17 1 15 I
lTe,mmHg 21 1 17 I
SFP,mmHg 53 2 71 2
P0,mmHg 66 1 84 ie
P,mmHg 35 1 33 I
Pc,mmHg 12 1 24 2
EFP,mmHg 18 2 18 1
SNGFRb, ni/mm 83 4 72 5
LW—lre,mmHg 14 4 16 1
a Values are the means SEM in eight dogs. Mean kidney
weight was 52.6 5.1 g. Abbreviations are RPP, renal perfusion
pressure; FF, filtration fraction; P1, proximal tubule pressure;
Ta, afferent colloid osmotic pressure; ITG, mean glomerular capil-
lary oncotic pressure; SFP, stop-flow pressure; PG, glomerular
capillary pressure; P, pentubular capillary pressure; EFP, ef-
fective filtration pressure; P, P0 — P1; ir = efferent colloid os-
motic pressure.
b SNGFR was measured in 5 dogs.
P < 0.01
Table 1. Total protein and albumin to globulin ratio in five dogs
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diuresis, averaging 18 1 mm Hg. SNGFR de-
creased slightly from 83 4 to 72 5 nhlmin (P =
NS); K was unchanged, averaging 4.6 0.4 before
and 4.0 0.4 ni/mm mm Hg after F. Attending the
vasodilation induced by F was a rise in P from 12
1 to 24 2 mm Hg (P < 0.01).
Similar data for eight other dogs whose RPP had
been reduced to slightly above the lower limit of au-
toregulation is presented in Table 3. At this lower
RPP, F administration failed to induce renal vasodi-
lation; RBF averaged 156 16 mI/mm before F and
151 15 mllmin after F. During F, GFR decreased
from 27 4 to 17 2 mI/mm (P < 0.01). FF de-
creased to a similar degree to that observed in the
first group of dogs, and sodium excretion increased
from 21 11 to 501 108 j.tEq/min (P < 0.01). Sev-
eral clear differences in response to F are apparent.
When F is administered while RPP is elevated, GFR
remains constant, UNaV is large, and RBF increases
significantly. In contrast, at reduced RPP, F admin-
istration is accompanied by a significant decrease in
GFR, UNaV is clearly not as large as when GFR is
maintained (although FENa remains constant), and
RBF does not increase.
Decreases in GFR could be attributed to direc-
tionally appropriate decreases in EFP, in K, or in
both. To determine if either or both of these
changes occurred, we performed micropressure and
SNGFR measurements. Because estimates of Kf
Table 3. Effect of furosemide on whole-kidney and
micropressure hemodynamic parameters at reduced renal
perfusion pressurea
Control Furosemide
Whole kidney
RPP,mmHg 104 2 97 2
GFR,mllmin 27 4 17 2C
RBF,ml/min 156 16 151 15
FF 0.25 0.02 0.19 0.O3
UaV,p.EqImin 21 11 501 108C
Micropressure
Pt, mm Hg 26 2 36 2'
ra,mmH9 12 1 12 1
ITG,mmHg 18 2 16 2
rre,mmHg 24 2 20 1
SFP,mmHg 47 3 47 2
PG,mmHg 59 1 59 1
P,mmHg 33 1 23 l
Pc,mmHg 14 2 20 2'
EFP, mm Hg 16 1 8 l'
SNGFRb, nI/mm 67 6 52 7d
ZW—lre,mmHg 9 2 3 I
a Values are the means SCM in eight dogs. Mean kidney
weight was 46.6 3.5 g. Abbreviations are defined in Table 2.
b SNGFR was measured in six dogs.
P < 0.01.
d P < 0.02.
necessitate knowledge of both EFP and SNGFR,
SNGFR was evaluated in six dogs at reduced RPP.
Free-flow PT was slightly lower at the reduced RPP
and averaged 26 2 mm Hg vs. 31 2 mm Hg at
endogenous RPP. During F, P increased signifi-
cantly to 36 2 mm Hg, yet this increase was 12
mm Hg less than that observed when F was given to
dogs whose RPP was 30 mm Hg higher. SFP was
also lower than in group-I dogs 47 3 vs. 53 2
mm Hg and also failed to increase with F. At endog-
enous RPP, estimated PG increased from 66 1 to
84 1 mm Hg; in contrast, at reduced RPP, esti-
mated PG did not increase, averaging 59 1 mm Hg
before and 59 1 mm Hg during F. Thus P de-
creased significantly from 33 1 mm Hg to 23 1
mm Hg at reduced RPP and remained constant at
endogenous RPP. At reduced RPP, SNGFR aver-
aged 67 6 nI/mm, and thus Kf averaged approxi-
mately 4.2 0.4 nhJminmm Hg. Following F,
SNGFR decreased to 52 7 nllmin (P < 0.02) at
reduced RPP; estimated Kf increased to 6.5 0.6
nI/minmm Hg (P = NS) at reduced RPP.
Renin release increases shortly after F adminis-
tration [73; the subsequent local generation of angio-
tensin II (All) might cause efferent arteriolar con-
striction, which would tend to elevate PG, thereby
maintaining zP and GFR. Thus, six additional stud-
ies were performed in an attempt to exclude a role
of the renin-angiotensin system in the maintenance
of GFR during F (Table 4). In our laboratory, the
dose of Sar1Gly8 (1 .tg/kg/min, i.v.) used in the pres-
ent studies was sufficient to inhibit the pressor re-
sponses to 500 ng of All administered exogenously.
Dogs in this group were studied at their endogenous
RPP (123 3 mm Hg). During the control period,
GFR and RBF averaged 33 4 mllmin and 204 27
mi/mm, respectively, and remained constant during
All antagonist infusion (32 4 and 194 26 mll
mm, NS). As demonstrated in Table 4, during F
diuresis, both PT and SFP increased 91% and 40%,
respectively, above control. Mean sodium excre-
Table 4. Effect of Sar'Gly8 on micropressure measurements
before and during furosemide diuresisa
Control Sar'Gly8
Sar'Gly8 and
furosemide
RPP,mmHg
PT,mmHg
123 3
34 2
126 434 2 125 465 6'
SFP,mmHg 56 2 58 3 80 5'
a Values are means SCM in six dogs. Abbreviations are RPP,
renal perfusion pressure; PT, proximal tubule pressure; SFP,
stop flow pressure.
b P < 0.1 compared to Sar1GIy8 alone.
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tion during F was quite variable; UNaV, however,
increased from 54 19 to 778 337 Eq/min, RBF
increased significantly to 249 31 mllmin (P <
0.05), and GFR fell slightly but significantly (P >
0.05) to 24 4 mhJmin.
Discussion
Although it is well known that furosemide has a
direct effect on electrolyte reabsorption in the as-
cending limb of Henle's loop [18], its reported effect
on GFR has been less consistent. Some studies
have demonstrated that GFR is depressed after fu-
rosemide [1, 2], whereas others have reported no
change in GFR [3, 4]. It should be noted that in
these studies, similar amounts of diuretic were
used, and urine losses were replaced with saline to
prevent extracellular fluid (ECF) volume con-
traction, which in itself can lead to decreased GFR
[3]. In many of these studies, little attention was
paid to simultaneous measurements of RPP and
RBF. To clarify how GFR can be altered during fu-
rosemide, we measured or estimated, using conven-
tional micropuncture techniques, some of the de-
terminants or factors that regulate GFR.
In the present investigation, whole kidney GFR
was unchanged following furosemide, when con-
comitant renal vasodilation was also demonstrable.
These events occurred when RPP was about 130
mm Hg. During furosemide, while both PT and SFP
increased, both zP and EFP remained unchanged.
This suggests that the increase in PT might have
been offset by a nearly proportional increase in PG.
The mechanism by which PG rose after furosemide
is not entirely clear, but may be related in part to
the vasodilation induced by this diuretic. At RPP
above the lower limit of RBF autoregulation, it has
been demonstrated that the afferent arterioles are
normally somewhat constricted, that is, renal vas-
cular resistance is above its minimum value [19]. At
this elevated RPP, administration of furosemide
could lead to increased RBF by causing afferent ar-
teriolar dilation [7]. Under these conditions, the rel-
atively higher mean systemic arterial pressure
should be more completely transmitted into the gb-
merular capillary network, thereby raising PG. An-
other possible explanation for the increased PG after
furosemide involves enhanced efferent arteriolar
construction; furosemide stimulates renin release
[20] and, therefore, elevates levels of All which can
increase efferent arteriolar resistance and thus in-
crease PG [21]. This effect, however, would also
cend to reduce RBF, a phenomena which was not
seen in the present study. Nevertheless, to examine
any possible contribution of increased All to elevat-
ing PG after furosemide, additional studies were per-
formed in the presence of an All antagonist
(Sar1Gly8). Despite the presence of this humoral an-
tagonist, SFP remained high after furosemide.
These results suggest that elevated plasma All lev-
els after furosemide administration do not play a
major role in maintaining PG via increased resis-
tance of the efferent arteriole. It is possible, how-
ever, that infused Sar'G1y8 may not have reached
the postglomerular sites, despite its ability to inhibit
the pressor response of exogenously administered
All.
Because furosemide has the ability under some
conditions to both increase RBF and raise PG, we
conducted another series of experiments at reduced
RPP (approximately 100 mm Hg). At this arterial
pressure, which approaches the lower limit of RBF
autoregulation, the afferent arterioles become rela-
tively more dilated to maintain RBF constant. The
mechanism by which this intrinsic adjustment in
RVR occurs is not well understood. As demon-
strated in the present study, furosemide did not in-
crease RBF at reduced RPP, possibly because the
afferent arterioles were already nearly maximally
dilated prior to diuretic administration. Never-
theless, while PG did not increase, PT did increase,
and a substantial natriuresis did occur during inhibi-
tion of loop reabsorption. Accordingly, zP and EFP
decreased by 30 and 50%, respectively, whereas
whole-kidney GFR was diminished by nearly 40%.
The results of these studies would suggest that in
experiments involving furosemide performed in a
setting where RPP is near the lower limit of RBF
autoregulation, a decrease in GFR would not be un-
expected. It is tempting to speculate that the reason
why GFR falls in many experimental conditions in
both man and conscious dogs is that the drug is ad-
ministered in a setting where RPP is already near
the lower limit of RBF autoregulation.
For these studies of the changes in GFR that have
been reported to occur following furosemide, we
considered the following as likely potential contri-
butions. First, decreased nephron plasma flow has
been shown to cause decreased nephron filtration
rate, at least in studies in the rat where filtration
equilibrium is demonstrable [22]. Because whole-
kidney GFR and RBF are probably related to both
single nephron filtration rate and single nephron
blood flow [22], we closely monitored RBF to deter-
mine if, indeed, decreases in RBF were present
when GFR was reduced. Second, decreased GFR
might be observed if a decrease in the ultrafiltration
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coefficient, K1, occurred during furosemide. Third,
decreased GFR might be observed if a decrease in
effective filtration pressure occurred during furose-
mide.
In the present studies, RBF did not decrease in
either group-I or group-Il animals; GFR decreased
only when furosemide was administered to dogs
whose RPP had been previously reduced. In addi-
tion, dogs in both groups were in filtration dis-
equilibrium during their respective control periods.
The net hydrostatic pressure favoring filtration at
the efferent end of the glomerular capillary was
greater than the calculated oncotic pressure oppos-
ing filtration by about 14 mm Hg at endogenous RPP
and about 9 mm Hg at the lower RPP. These data
confirm the observations of Ott et al [15] and Navar
et al [13] that the dog is normally in filtration dis-
equilibrium. Thus, the first possibility, that of a
plasma flow-dependent change in GFR could not be
invoked by our studies.
The second consideration concerning a mecha-
nism responsible for decreased GFR concerns de-
creased K1 during furosemide. To evaluate this pos-
sibility, we estimated K1 at both reduced RPP and
endogenous RPP. Navar et al [13] have suggested
that K1 would not be expected to change simply
with altered RPP. Osswald et al recently provided
experimental evidence to support this suggestion
[24]. In addition, there is no evidence suggesting
that furosemide alone decreases K1 (which would
lead to a decrease in GFR) or that decreased K1
might occur at low RPP but not at endogenous RPP
[24]. Our estimates of K1 suggest that K1 is similar at
both endogenous (4.6 0.4 nlJminmm Hg) and re-
duced RPP (4.2 0.4 nllminmm Hg) prior to fu-
rosemide administration. After furosemide, K1 in-
creased slightly at reduced RPP and decreased
slightly at endogenous RPP (both P = NS). Thus,
our second consideration, that at reduced RPP de-
creases in GFR following furosemide might be due
to decreased K1, was not supported by these stud-
ies.
For these studies of K1, certain assumptions were
made. The dog kidney does not have surface gb-
meruli, and only indirect estimates of PG can be at-
tained. The technique involves oil blockade of the
nephron until upstream pressure reaches a maxi-
mum. Studies by Ott et al [15], Arendshorst, Finn,
and Gottschalk [23] and Azar et al [25] have clearly
demonstrated that in Munich-Wistar rats, which
possess surface glomeruli, direct measurements of
PG agree closely with values obtained in the same
animals using the indirect stop-flow technique. We
also must acknowledge that the indirect technique
has been shown to overestimate PG in some studies
[25]. Navar et al [26] have suggested that true PG
can only be estimated with certainty when RPP is at
or near the lower limit of RBF autoregulation. This
technical artifact may exist when RPP is above the
lower limit of autoregulation, because, under these
circumstances, oil blockade of a single nephron re-
duces distal delivery, and may lead to feedback-
mediated afferent arteriolar dilation and a con-
comitant rise in PG. The magnitude of the rise seems
to be directly dependent upon the level of arterial
blood pressure [26]. Nevertheless, errors in the
measurement of SFP and PG are minimized greatly
if the RPP is reduced to a point near, but above, the
lower limit of RBF autoregulation. Although it is
speculative to draw conclusions from different
groups of dogs, it does appear that SFP, a com-
ponent of calculated PG, was higher (53 mm Hg)
when measured in dogs at endogenous RPP (131
mm Hg) than it was (47 mm Hg) in dogs at reduced
RPP (104 mm Hg). Furthermore, even if each is an
overestimate, SFP obtained at reduced RPP is prob-
ably closer to the true SFP. Thus, in estimating K1
which necessarily involved estimating PG. we as-
sumed that SFP measurements obtained at sub-
stantially reduced RPP were more likely to be sub-
ject to minimal artifactual errors. The results of
these estimates agree closely with those obtained at
endogenous RPP, which may be due to the fact that,
as has been pointed out by Osswald et a! [24], in
estimating K1 both SNGFR and SFP are subjected
to the same potential influences resulting from de-
creased distal delivery.
In the present experiments, we also estimated ire
indirectly by using whole-kidney filtration fraction
and systemic oncotic pressure. Studies by Knox et
al [14] and Ott et a! [15] have confirmed that the
indirect estimates correlate well with more direct
determinations of postgbomerular oncotic pressure.
Our estimates of FF based upon superficial hemato-
crit and whole-kidney hematocrit are reasonably
close to one another, suggesting that the use of
whole-kidney FF to estimate superficial FF is a
useful approximation. irG was evaluated from (ira +
lTe)12 because AP was 30 to 60% higher than ire. Both
Deen et al and Knox et al concur that this approxi-
mation and a more vigorous integrated result give
similar results when the conditions of filtration dis-
equilibrium are present and similar to those of the
present study [16, 17].
The final consideration in assessing why GFR de-
creases in some experiments involving furosemide
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concerned a potential decrease in EFP. Since ITGdid
not change appreciably, any decrease in EFP can be
attributed to a decrease in zP. Because P in the
dog is a derived term, we wished to be appropriate-
ly cautious in interpreting our measurements. As
pointed out previously, artifacts in these measure-
ments of SFP (and therefore of PG) are less likely to
be encountered at the lower limit of autoregulation.
Thus, our estimates of P were made at reduced
RPP both before and during furosemide; the results
demonstrate that during furosemide there occurs a
clear reduction in zP at a time when GFR is also
decreased to nearly the same proportion. In a simi-
lar manner, SFP (and PG) measurements obtained at
the endogenous RPP, although being suspect quan-
titatively, are consistent with a constancy of both
GFR and zP.
The mechanism by which PT rose following fu-
rosemide was not examined in the present study. It
is reasonable to assume, however, that the increase
in tubular hydrostatic pressure is due to inhibition
of electrolyte reabsorption in the ascending limb of
Henle's loop. This conclusion is strengthened by
the substantial increase in UNaV observed in the
present study. In addition, furosemide might also
have an effect on proximal tubular reabsorption
which would also contribute to the PT elevation [3].
The presence of a feedback-related dilation of the
afferent arteriole, if maximal during the measure-
ment of SFP, requires that we explain the observed
further rise in SFP in dogs given furosemide while
RPP was elevated. It might be that all afferent arte-
rioles (rather than only that of a single nephron) are
dilated during furosemide. This dilation and the cor-
responding increase in pressure in vascular and
tubular compartments could mechanically raise the
pressure(s) at multiple intrarenal sites, that is, capil-
lary, proximal tubule, and glomerular capillaries,
especially within the constraints imposed by the in-
creased volume of blood passing through the kidney
and the limited distensibility of the renal capsule. In
agreement with this suggestion, we did observe in-
creases in all measured pressures (that is, P, PT,
and PG) during furosemide administration at endog-
enous RPP.
Summary. We have found that during furosemide
diuresis at a RPP at which the kidney can exhibit
renal vasodilation, whole-kidney GFR, and P re-
main constant, whereas RBF increases. When fu-
rosemide, however, is administered at RPP near
lower limit of RBF autoregulation where RBF does
not increase, glomerular filtration and P decrease
substantially. These results suggest that changes in
zW, which are related to the starting level of RPP,
determine whether GFR remains constant or falls
during furosemide administration.
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